The Lakewood, CO-based company was a subsidiary of Gambro AB, a previously publicly traded, multinational healthcare company based in Sweden. It currently operates as an independent U.S. corporation under a private ownership structure.
David B. Perez, President and Chief Executive Officer said, CaridianBCT is built on a 44-year tradition of partnering with customers to provide superior products, services and technology. Our vision, ‘for better blood and better lives’ is accomplished by being a leading global provider of products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies.
The company is a leader in the blood bank technology industry, investing in research and development focused on enhancing blood quality, safety, supply and efficiency. Our Trima Accel®, COBE® Spectra and Spectra Optia® as well as our European Mirasol® and Atreus® systems are widely recognized as delivering the highest value and quality to customers around the world, said Perez. Under new name, CaridianBCT will continue to be a pioneer in blood banking and transfusion medicine, developing and commercializing innovation that meets the needs of our customers and the patients they serve.
